Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pfizer and the European Foundation for the Study of Diabetes has reported the development of a new awards program which will provide research grants to support European research around understanding and reducing cardiovascular risk in patients with diabetes.
Subscribe to our email newsletter
According to Pfizer, grants will be awarded for research focusing on fostering a clearer understanding of cardiovascular risk-reduction strategies, such as educational programs, risk-assessment tools, screenings and clinical interventions.
Dr Lance Berman, senior medical director for Pfizer, said: “Pfizer is proud to partner with the European Foundation for the Study of Diabetes on this new research initiative. As part of our commitment to the care of patients with diabetes, Pfizer is dedicated to supporting research that will help identify ways to reduce these risks, further our understanding of optimal treatment options, and ultimately improve the lives of the people with diabetes.”